Table 1.
Clinicopathologic features for the glioma patients
| Characteristics | Group | ||
|---|---|---|---|
| Age (years) | IDH- wildtype |
IDH-mutation 1p/19q intact | IDH-mutation 1p/19q codeletion |
| 1~10 | 0 | 0 | 0 |
| 11~20 | 0 | 7 | 2 |
| 21~30 | 13 | 55 | 13 |
| 31~40 | 13 | 84 | 45 |
| 41~50 | 30 | 48 | 32 |
| 51~60 | 66 | 19 | 37 |
| 61~70 | 64 | 9 | 15 |
| 71~80 | 31 | 1 | 6 |
| 81~90 | 8 | 0 | 0 |
| 91~100 | 0 | 0 | 0 |
| Histology | |||
| oligodendroglioma | 19 | 37 | 116 |
| oligoastrocytoma | 15 | 67 | 30 |
| astrocytoma | 52 | 110 | 4 |
| glioblastoma | 139 | 9 | 0 |
| Grade | |||
| G2 | 19 | 114 | 80 |
| G3 | 67 | 100 | 70 |
| G4 | 139 | 9 | 0 |
| Gender | |||
| Male | 137 | 130 | 83 |
| Female | 88 | 93 | 67 |
| Vital Status | |||
| Alive | 68 | 206 | 145 |
| Dead | 165 | 48 | 21 |
| Days to Death (mean±SD) | 466±570 | 1068±957 | 1003±976 |
| Median Days to Death | 382 | 836 | 710.5 |